June 14 [US/CAN] @ 1pm ET / 10am PT | [EU] @ 7pm CET / 6pm GMT | [AU] @ 3am AEDT (June 15)

Canine lymphoma is a common and debilitating disease that up until now has been a struggle to detect early and monitor through treatment. Those difficult days are nearing an end thanks to recent advances in epigenetics. Attend this free 1-hr webinar to hear about Heska Nu.Q® Canine Cancer Screen and Monitor, a breakthrough in cancer monitoring in-clinic, from Veterinary Oncologist Dr. Heather Wilson-Robles, Chief Medical Officer of Volition Veterinary and Past President of the Veterinary Cancer Society. Dr. Wilson-Robles will discuss recent research into utilizing Nu.Q® to monitor patients undergoing treatment for lymphoma.

Attend this webinar to learn about:

  • Current methods to monitor treatment and disease progress
  • Clinical study on monitoring lymphoma progression using nucleosomes
  • Discussion on how to use Nu.Q® to guide treatment and monitor progress
  • Comparison between nucleosomes, c-reactive protein, and thymidine kinase

This program has been submitted (but is not yet approved) for 1 hour of continuing education credit in jurisdictions which recognize RACE approval. NOTE: If the program is approved for CE credit, you must watch the webinar LIVE to earn the CE credit.

Co-Sponsored by: 

Volition Veterinary